National Bank of Canada FI Cuts Position in Bausch Health Companies Inc. (NYSE:BHC)

National Bank of Canada FI decreased its stake in Bausch Health Companies Inc. (NYSE:BHC) by 0.1% in the 4th quarter, Holdings Channel reports. The firm owned 15,649,539 shares of the company’s stock after selling 12,185 shares during the quarter. National Bank of Canada FI’s holdings in Bausch Health Companies were worth $121,751,000 at the end of the most recent reporting period.

Other institutional investors have also recently added to or reduced their stakes in the company. Commonwealth Equity Services LLC boosted its position in Bausch Health Companies by 16.3% during the third quarter. Commonwealth Equity Services LLC now owns 45,699 shares of the company’s stock worth $376,000 after purchasing an additional 6,399 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank grew its stake in Bausch Health Companies by 15.1% in the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 56,783 shares of the company’s stock valued at $470,000 after acquiring an additional 7,465 shares during the last quarter. Mackenzie Financial Corp increased its holdings in Bausch Health Companies by 8.1% during the 3rd quarter. Mackenzie Financial Corp now owns 1,231,232 shares of the company’s stock valued at $9,869,000 after acquiring an additional 92,515 shares in the last quarter. Park Avenue Securities LLC acquired a new position in Bausch Health Companies during the third quarter worth about $169,000. Finally, TD Asset Management Inc lifted its holdings in shares of Bausch Health Companies by 17.5% in the third quarter. TD Asset Management Inc now owns 1,137,247 shares of the company’s stock valued at $9,421,000 after purchasing an additional 169,531 shares in the last quarter. Hedge funds and other institutional investors own 78.65% of the company’s stock.

Bausch Health Companies Price Performance

Shares of BHC stock traded down $0.27 during mid-day trading on Friday, hitting $7.82. 3,396,646 shares of the company’s stock were exchanged, compared to its average volume of 3,868,373. Bausch Health Companies Inc. has a fifty-two week low of $5.57 and a fifty-two week high of $11.46. The stock has a 50-day simple moving average of $9.26 and a two-hundred day simple moving average of $8.21.

Bausch Health Companies (NYSE:BHC) last released its earnings results on Thursday, February 22nd. The company reported $1.15 earnings per share for the quarter, topping the consensus estimate of $1.01 by $0.14. The firm had revenue of $2.41 billion for the quarter, compared to the consensus estimate of $2.29 billion. Bausch Health Companies had a negative return on equity of 8,504.35% and a negative net margin of 5.07%. The firm’s revenue for the quarter was up 9.8% compared to the same quarter last year. During the same period in the prior year, the business posted $1.02 earnings per share. Equities research analysts expect that Bausch Health Companies Inc. will post 3.96 EPS for the current year.

Wall Street Analysts Forecast Growth

BHC has been the subject of a number of recent research reports. Jefferies Financial Group dropped their price objective on shares of Bausch Health Companies from $16.00 to $14.00 and set a “buy” rating for the company in a research note on Tuesday, February 20th. Piper Sandler lifted their price objective on Bausch Health Companies from $7.00 to $9.00 and gave the stock a “neutral” rating in a research report on Monday, April 29th. StockNews.com raised shares of Bausch Health Companies from a “hold” rating to a “buy” rating in a research note on Wednesday, February 7th. Finally, Royal Bank of Canada decreased their price target on shares of Bausch Health Companies from $12.00 to $11.00 and set a “sector perform” rating on the stock in a research note on Tuesday, April 23rd. Three research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $11.33.

Bausch Health Companies Profile

Bausch Health Companies Inc operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health.